The Multidimensional Pathogenesis of Susceptibility to Depression in Sjögren’s Syndrome: An Integrated Approach from Immune–Inflammatory to Psychosocial Factors
- 1First School of Clinical Medicine, Yunnan University of Chinese Medicine, Kunming 510499, China
Abstract
Sjögren’s syndrome is a chronic systemic autoimmune disease with primary (pSS) and secondary forms. Epidemiological evidence suggests a higher prevalence of depressive symptoms and depression in pSS than in the general population, indicating possible disease-specific susceptibility. The underlying mechanisms remain unclear, limiting early identification and targeted intervention. This narrative review examines five domains of depression susceptibility in pSS: inflammatory pathways, neuroendocrine regulation, the gut–brain axis, medication effects, and psychosocial factors. Interleukin-6, tumor necrosis factor-α, and interferon-α may contribute by activating the indoleamine 2,3-dioxygenase–kynurenine pathway, downregulating brain-derived neurotrophic factor, and inhibiting hippocampal neurogenesis. Hypothalamic–pituitary–adrenal axis dysfunction may provide a neuroendocrine link, whereas gut microbial imbalance may affect emotional regulation through immune and neural signaling. Glucocorticoids, hydroxychloroquine, and calcineurin inhibitors may increase neuropsychiatric risk through multiple pathways. Somatic symptoms and social stress may reinforce a psychosocial vicious cycle. Much of the mechanistic evidence comes from major depressive disorder, animal models, or in vitro studies; causality has not been established in pSS. The proposed multidimensional model is hypothetical and offers a framework for early screening and targeted intervention in pSS with depression.
Related
- Editorial: The role of RNA regulation in cancer pathogenesis and therapeutic strategies
- Pathogenesis of Calcium Oxalate Kidney Stones, Interactions Among Mitochondria, NADPH Oxidase and Endoplasmic Reticulum
- From Dysbiosis to Disease: How Vaginal Microbiota Shape Group B Streptococcus Pathogenesis
- The role of mitochondrial DNA and RNA in promoting liver disease pathogenesis
- Extracellular Vesicles in Molecular Crosstalk and Disease Pathogenesis: A Comprehensive Review on Mechanisms and Therapeutic Prospects
BibTeX
@article{he2026multidimensional,
title = {{The Multidimensional Pathogenesis of Susceptibility to Depression in Sjögren’s Syndrome: An Integrated Approach from Immune–Inflammatory to Psychosocial Factors}},
author = {Qiumei He and Xiaoqiao Gu and Qianqian Yang and Niqin Xiao and Xi Liu and Kuanmeng Chi and Zhaohu Xie and Zhaofu Li},
journal = {International Journal of Molecular Sciences},
year = {2026},
month = nov,
doi = {10.3390/ijms272110038},
url = {https://www.mdpi.com/1422-0067/27/21/10038},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - The Multidimensional Pathogenesis of Susceptibility to Depression in Sjögren’s Syndrome: An Integrated Approach from Immune–Inflammatory to Psychosocial Factors
AU - Qiumei He
AU - Xiaoqiao Gu
AU - Qianqian Yang
AU - Niqin Xiao
AU - Xi Liu
AU - Kuanmeng Chi
AU - Zhaohu Xie
AU - Zhaofu Li
PY - 2026
DA - 2026/11/09
JO - International Journal of Molecular Sciences
DO - 10.3390/ijms272110038
UR - https://www.mdpi.com/1422-0067/27/21/10038
AB - Sjögren’s syndrome is a chronic systemic autoimmune disease with primary (pSS) and secondary forms. Epidemiological evidence suggests a higher prevalence of depressive symptoms and depression in pSS than in the general population, indicating possible disease-specific susceptibility. The underlying mechanisms remain unclear, limiting early identification and targeted intervention. This narrative review examines five domains of depression susceptibility in pSS: inflammatory pathways, neuroendocrine regulation, the gut–brain axis, medication effects, and psychosocial factors. Interleukin-6, tumor necrosis factor-α, and interferon-α may contribute by activating the indoleamine 2,3-dioxygenase–kynurenine pathway, downregulating brain-derived neurotrophic factor, and inhibiting hippocampal neurogenesis. Hypothalamic–pituitary–adrenal axis dysfunction may provide a neuroendocrine link, whereas gut microbial imbalance may affect emotional regulation through immune and neural signaling. Glucocorticoids, hydroxychloroquine, and calcineurin inhibitors may increase neuropsychiatric risk through multiple pathways. Somatic symptoms and social stress may reinforce a psychosocial vicious cycle. Much of the mechanistic evidence comes from major depressive disorder, animal models, or in vitro studies; causality has not been established in pSS. The proposed multidimensional model is hypothetical and offers a framework for early screening and targeted intervention in pSS with depression.
SN - 1422-0067
ER -